Business

Global Virus Filtration Market Size By Type, By Application, By End-user, By Geographic Scope And Forecast

_x000D_

_x000D_

Virus Filtration Market size was valued at USD 4526.12 Million in 2024 and is projected to reach USD 10712.03 Million by 2031, growing at a CAGR of 11.37% from 2024 to 2031.

_x000D_

Virus Filtration market is estimated to grow at a CAGR of 11.37% & reach USD 10712.03 Mn by the end of 2031Virus Filtration market is estimated to grow at a CAGR of 11.37% & reach USD 10712.03 Mn by the end of 2031

_x000D_

_x000D_
_x000D_

Global Virus Filtration Market Drivers

_x000D_

The market drivers for the Virus Filtration Market can be influenced by various factors. These may include:

_x000D_

    _x000D_

  • Boosting the Production of Biopharmaceuticals: Efficient viral filtration techniques are necessary to preserve the safety and purity of biologics, which include monoclonal antibodies, vaccines, and therapeutic proteins, due to the growing demand for these products.
  • _x000D_

  • Increasing Rate of Chronic Illnesses: The demand for biopharmaceutical goods has increased because to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has resulted in a greater requirement for viral filtering to preserve the integrity of these medicines.
  • _x000D_

  • Tight Regulating Guidelines: Strict regulations are in place for viral safety in the manufacturing of biopharmaceuticals from regulatory organisations including the FDA and EMA. Advanced viral filtration technologies are required in order to comply with these criteria.
  • _x000D_

  • Technological Progress: High-capacity filters and sophisticated filtration systems are examples of virus filtration innovations that have improved efficiency and dependability, making them more appealing to biopharmaceutical businesses.
  • _x000D_

  • Growing R&D Investment: One important factor driving the market is biopharmaceutical firms’ increased expenditure in R&D to create novel and enhanced viral filtration techniques.
  • _x000D_

  • Growth of the Biotechnology Industry: The biotechnology sector is expanding quickly, especially in developing nations, which increases the need for services and goods related to viral filtering.
  • _x000D_

  • Pay Attention to Generics and Biosimilars: The demand for virus filtration technologies is driven by the expanding market for biosimilars and generic biologics, which need strict virus filtration procedures to match the quality of original biologics.
  • _x000D_

  • Growing Viral Contamination Incidence: The use of virus filtration as an essential safety precaution has expanded due to awareness of and worry over viral contamination in biopharmaceutical products.
  • _x000D_

  • Acceptance of One-Time Use Technologies: The market for viral filtration is expanding due to the tendency in biopharmaceutical manufacturing towards single-use systems because of their low cost and lower danger of cross-contamination.
  • _x000D_

  • Component Manufacturing Organisations (CMOs) are Growing: The need for superior virus filtering solutions to satisfy a range of customer demands is fueled by the growing significance of CMOs in the biopharmaceutical production process.
  • _x000D_

_x000D_

Global Virus Filtration Market Restraints

_x000D_

Several factors can act as restraints or challenges for the Virus Filtration Market. These may include:

_x000D_

    _x000D_

  • High Filtration System Cost: The cost of virus filtration systems and related consumables makes it difficult for small and medium-sized businesses to afford them. This expensive initial outlay may act as a major deterrent to adoption and admission.
  • _x000D_

  • Sophisticated and Tight Regulatory Needs: The biopharmaceutical sector is heavily regulated, and strict rules for viral filtering are in place to guarantee the safety of the products. It may take a while and be expensive to comply with these rules, which could postpone product development and market launch.
  • _x000D_

  • Technology Difficulties: It is theoretically difficult to create efficient viral filtering systems that can handle different kinds of viruses without lowering the product’s quality or production. The development and application of new filtration methods may be slowed down by these complications.
  • _x000D_

  • Restricted Skilled Labour: Systems for filtering viruses require specific knowledge and abilities to operate. The insufficiency of skilled personnel to oversee these intricate systems can impede the expansion of the sector.
  • _x000D_

  • Problems with the supply chain: Equipment and consumables used in viral filtration have a susceptible supply chain. Critical parts and resources may become scarce due to events like pandemics, natural disasters, or unstable geopolitical conditions.
  • _x000D_

  • Competitive Environment: The market for viral filtering is extremely competitive, with well-established companies holding a dominant position. Due to their strong market presence and devoted clientele, these well-established businesses may be tough for newcomers to compete with.
  • _x000D_

  • Economic Recessions: Funding for research and development in the biopharmaceutical industry may be impacted by economic volatility or recession. Decreased funding may result in less money being invested on novel viral filtration techniques and technologies.
  • _x000D_

_x000D_

Global Virus Filtration Market Segmentation Analysis

_x000D_

The Global Virus Filtration Market is segmented on the basis of Type, Application, End-User, And Geography.

_x000D_

Virus Filtration Market Segments Analysis Virus Filtration Market Segments Analysis Virus Filtration Market, By Type

_x000D_

    _x000D_

  •  Kits and Reagents
  • _x000D_

  •  Services
  • _x000D_

  •  Filtration Systems
  • _x000D_

  •  Others
  • _x000D_

_x000D_

Based on Type, the market is segmented into kits and reagents, services, filtration systems, and others. Kits and Reagents accounted for the largest market share in 2021, and is projected to grow at a CAGR of 11.72% during the forecast period. The reagents help identify viruses that may contaminate the cell substrate or other reagents or materials used in the evaluation process. Qiagen and Merck Millipore are two well-known manufacturers of reagents and kits for virus filtration. Blood, plasma, serum, bodily fluids, and any monoclonal antibody and recombinant proteins are used in the production of biopharmaceuticals.

_x000D_

Virus Filtration Market, By Application

_x000D_

    _x000D_

  •  Medical Devices
  • _x000D_

  •  Water Purification
  • _x000D_

  •  Air Purification
  • _x000D_

  •  Biologicals
  • _x000D_

  • Vaccines and Therapeutics
  • _x000D_

  •  Blood and Blood Products
  • _x000D_

  •  Cellular and Gene Therapy Products
  • _x000D_

  •  Others
  • _x000D_

_x000D_

Based on Application, the market is segmented into medical devices, water purification, air purification, and biologicals. Biologicals accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 12.08% during the forecast period. Biologicals are being used to treat and correct a wide range of medical situations and metabolic dysfunctions. Virus removal methods involve size exclusion, including filtration, adsorption to specific matrices, including chromatography, and partitioning into a different fraction. Filtration methodologies designed for viral removal applications considerably contribute to a reduction of endogenous and adventitious viral contaminants.

_x000D_

Virus Filtration Market, By End-User

_x000D_

    _x000D_

  •  Pharmaceutical & Biotechnology Companies
  • _x000D_

  •  Contract Research Organizations
  • _x000D_

  •  Academic Research Institutes
  • _x000D_

  •  Medical Device Companies
  • _x000D_

_x000D_

Based on End-user, the global virus filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Pharmaceutical & Biotechnology Companies accounted for the largest market share in 2020, and is projected to grow at a CAGR of 11.64% during the forecast period. The increasing geriatric population and the rising majority of chronic medical disorders positively impact the market growth. Also, the growing need for potential therapies and vaccines to treat patients in critical conditions using viral filtration in convalescent plasma to minimize inflammatory mediators. The continued advancement of bioprocessing technologies such as disposable devices, perfusion reactors, and chromatographic resins increases the global demand for pharmaceutical & biotechnology companies.

_x000D_

Virus Filtration Market, By Geography

_x000D_

    _x000D_

  •  North America
  • _x000D_

  •  Europe
  • _x000D_

  •  Asia Pacific
  • _x000D_

  •  Rest of the world.
  • _x000D_

_x000D_

On the basis of regional analysis, the Global Virus filtration Market is classified into North America, Europe, Asia Pacific and Rest of the world, North America accounted for the largest market share in 2021, and is projected to grow at the highest CAGR during the forecast period. The viral filtration industry in North America continued to hold a significant market share in comparison to the other regions. As the region’s leading position, particularly in the United States, to follow automation in healthcare procedures. Moreover, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the region contains several well-known firms. Europe was the second-largest market in 2021, and it is projected to grow at a CAGR.

_x000D_

Key Players

_x000D_

The major players in the Virus Filtration Market are:

_x000D_

    _x000D_

  • Merck & Co.
  • _x000D_

  • GE Healthcare
  • _x000D_

  • Thermo Fisher Scientific Inc.
  • _x000D_

  • Lonza Group Ltd.
  • _x000D_

  • Pall Corporation
  • _x000D_

  • Charles River Laboratories
  • _x000D_

  • Sartorius AG
  • _x000D_

  • Asahi Kasei Medical Co., Ltd.
  • _x000D_

  • WuXi AppTec
  • _x000D_

_x000D_

Report Scope

_x000D_

REPORT ATTRIBUTES DETAILS
STUDY PERIOD

2021-2031

_x000D_

BASE YEAR

2024

_x000D_

FORECAST PERIOD

2024-2031

_x000D_

HISTORICAL PERIOD

2021-2023

_x000D_

UNIT

Value (USD Million)

_x000D_

KEY COMPANIES PROFILED

Merck & Co., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories, Sartorius AG, Asahi Kasei Medical Co., Ltd., and WuXi AppTec.

_x000D_

SEGMENTS COVERED

By Type, By Application, By End-user, And By Geography

_x000D_

CUSTOMIZATION SCOPE

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

_x000D_

_x000D_

Research Methodology of Market Research

_x000D_

Research Methodology Research Methodology

_x000D_

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Market Research.

_x000D_

Reasons to Purchase this Report

_x000D_

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
_x000D_
• Provision of market value (USD Billion) data for each segment and sub-segment
_x000D_
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
_x000D_
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
_x000D_
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
_x000D_
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
_x000D_
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
_x000D_
• Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis
_x000D_
• Provides insight into the market through Value Chain
_x000D_
• Market dynamics scenario, along with growth opportunities of the market in the years to come
_x000D_
• 6-month post-sales analyst support

_x000D_

Customization of the Report

_x000D_

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

_x000D_

Frequently Asked Questions

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_
Virus Filtration Market size was valued at USD 4526.12 Million in 2024 and is projected to reach USD 10712.03 Million by 2031, growing at a CAGR of 11.37% from 2024 to 2031._x000D_
_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_
The global virus filtration market has witnessed strong growth owing to the increasing number of chronic diseases, including cancer, diabetes, and autoimmune disorders._x000D_
_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_
The major players are Merck & Co., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories, Sartorius AG, Asahi Kasei Medical Co., Ltd., and WuXi AppTec._x000D_
_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_
The Global Virus Filtration Market is segmented on the basis of Type, Application, End-User And Geography._x000D_
_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_
The sample report for the Virus Filtration Market can be obtained on demand from the website. Also, 24*7 chat support & direct call services are provided to procure the sample report._x000D_
_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_

_x000D_
{“@context”:”https:\/\/schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What is the projected market size & growth rate of the Virus Filtration Market?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Virus Filtration Market size was valued at USD 4526.12 Million in 2024 and is projected to reach USD 10712.03 Million by 2031, growing at a CAGR of 11.37%\u00a0from 2024 to 2031.\n Read More..”}},{“@type”:”Question”,”name”:”What are the key driving factors for the Virus Filtration Market?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The global virus filtration market has witnessed strong growth owing to the increasing number of chronic diseases, including cancer, diabetes, and autoimmune disorders.\n Read More..”}},{“@type”:”Question”,”name”:”What are the top players operating in the Virus Filtration Market?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The major players are Merck & Co., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories, Sartorius AG, Asahi Kasei Medical Co., Ltd., and WuXi AppTec.\n Read More..”}},{“@type”:”Question”,”name”:”What segments are covered in the Virus Filtration Market?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The Global Virus Filtration Market is segmented on the basis of Type, Application, End-User And Geography.\n Read More..”}},{“@type”:”Question”,”name”:”How can I get a sample reports\/company profiles for the Virus Filtration Market?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The sample report for the Virus Filtration Market can be obtained on demand from the website. Also, 24*7 chat support & direct call services are provided to procure the sample report.\n Read More..”}}]}_x000D_

_x000D_